Form 4 for MNPR Monopar Therapeutics
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-04 · accession 0001437749-25-006736 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-07 | 2025-03-04 | MNPR | Robinson Chandler | CEO, Dir | M - OptEx | — | +6,002 | 64.8K | +10% | — |
| D | 2025-03-07 | 2025-03-04 | MNPR | Robinson Chandler | CEO, Dir | F - Tax | $31.70 | -1,759 | 63.1K | -3% | -$55.8K |
| DM | 2025-03-07 | 2025-03-04 | MNPR | Robinson Chandler | CEO, Dir | A - Grant | $0.00 | +165.7K | 85.8K | New | $0 |
| D | 2025-03-07 | 2025-03-04 | MNPR | Robinson Chandler | CEO, Dir | M - OptEx | $0.00 | -6,002 | 98.8K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | M | A | 6,002 | — | 64,850 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Common | Common Stock | 2025-03-04 | F | D | 1,759 | $31.70 | 63,091 | D | — | — | (F2) Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-03-04 | A | A | 79,899 | $0.00 | 104,777 | D | $0.00 · — to — | 79,899 Common Stock | (F4) 6,002 restricted stock units vested on the grant date. Remainder of restricted stock units vest 6/48ths on June 30, 2025, and 3/48ths per quarter thereafter. |
| 4 | Derivative | Restricted Stock Units | 2025-03-04 | M | D | 6,002 | $0.00 | 98,775 | D | — · — to — | 6,002 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F6) Represents vesting of 6,002 restricted stock units on the grant date. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |
| 5 | Derivative | Stock Options | 2025-03-04 | A | A | 85,759 | $0.00 | 85,759 | D | $31.70 · — to 2035-03-04 | 85,759 Common Stock | (F3) 6,647 options vested on the grant date. Remainder of options vest 6/48ths on June 30, 2025, and 1/48th per month thereafter. |